353 related articles for article (PubMed ID: 28400718)
1. Rab GTPases: The Key Players in the Molecular Pathway of Parkinson's Disease.
Shi MM; Shi CH; Xu YM
Front Cell Neurosci; 2017; 11():81. PubMed ID: 28400718
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of Rab GTPases in the pathogenesis of Parkinson's disease.
Gao Y; Wilson GR; Stephenson SEM; Bozaoglu K; Farrer MJ; Lockhart PJ
Mov Disord; 2018 Feb; 33(2):196-207. PubMed ID: 29315801
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's: A Disease of Aberrant Vesicle Trafficking.
Singh PK; Muqit MMK
Annu Rev Cell Dev Biol; 2020 Oct; 36():237-264. PubMed ID: 32749865
[TBL] [Abstract][Full Text] [Related]
4. The role of Rab GTPases in the pathobiology of Parkinson' disease.
Bonet-Ponce L; Cookson MR
Curr Opin Cell Biol; 2019 Aug; 59():73-80. PubMed ID: 31054512
[TBL] [Abstract][Full Text] [Related]
5. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.
Jeong GR; Jang EH; Bae JR; Jun S; Kang HC; Park CH; Shin JH; Yamamoto Y; Tanaka-Yamamoto K; Dawson VL; Dawson TM; Hur EM; Lee BD
Mol Neurodegener; 2018 Feb; 13(1):8. PubMed ID: 29439717
[TBL] [Abstract][Full Text] [Related]
7. The Role of Rab Proteins in Parkinson's Disease Synaptopathy.
Bellucci A; Longhena F; Spillantini MG
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009486
[TBL] [Abstract][Full Text] [Related]
8. A pathogenic variant in RAB32 causes autosomal dominant Parkinson's disease and activates LRRK2 kinase.
Gustavsson EK; Follett J; Trinh J; Barodia SK; Real R; Liu Z; Grant-Peters M; Fox JD; Appel-Cresswell S; Stoessl AJ; Rajput A; Rajput AH; Auer R; Tilney R; Sturm M; Haack TB; Lesage S; Tesson C; Brice A; Vilariño-Güell C; Ryten M; Goldberg MS; West AB; Hu MT; Morris HR; Sharma M; Gan-Or Z; Samanci B; Lis P; Tocino T; Amouri R; Sassi SB; Hentati F; ; Tonelli F; Alessi DR; Farrer MJ
medRxiv; 2024 Jan; ():. PubMed ID: 38293014
[TBL] [Abstract][Full Text] [Related]
9. The Emerging Functions of LRRK2 and Rab GTPases in the Endolysosomal System.
Kuwahara T; Iwatsubo T
Front Neurosci; 2020; 14():227. PubMed ID: 32256311
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Parkinson's disease-related pathogenic TMEM230 mutants.
Nam D; Kim H; Choi DJ; Bae YH; Lee BD; Son I; Seol W
Anim Cells Syst (Seoul); 2018; 22(2):140-147. PubMed ID: 30460091
[TBL] [Abstract][Full Text] [Related]
11. Novel gene (TMEM230) linked to Parkinson's disease.
Olszewska DA; Fearon C; Lynch T
J Clin Mov Disord; 2016; 3():17. PubMed ID: 27872751
[TBL] [Abstract][Full Text] [Related]
12. Rabs, Membrane Dynamics, and Parkinson's Disease.
Tang BL
J Cell Physiol; 2017 Jul; 232(7):1626-1633. PubMed ID: 27925204
[TBL] [Abstract][Full Text] [Related]
13. The LRRK2-RAB axis in regulation of vesicle trafficking and α-synuclein propagation.
Bae EJ; Lee SJ
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165632. PubMed ID: 31812666
[TBL] [Abstract][Full Text] [Related]
14. LRRK2 and Rab GTPases.
Pfeffer SR
Biochem Soc Trans; 2018 Dec; 46(6):1707-1712. PubMed ID: 30467121
[TBL] [Abstract][Full Text] [Related]
15. The Parkinson's disease-linked protein TMEM230 is required for Rab8a-mediated secretory vesicle trafficking and retromer trafficking.
Kim MJ; Deng HX; Wong YC; Siddique T; Krainc D
Hum Mol Genet; 2017 Feb; 26(4):729-741. PubMed ID: 28115417
[TBL] [Abstract][Full Text] [Related]
16. Dysfunction of RAB39B-Mediated Vesicular Trafficking in Lewy Body Diseases.
Koss DJ; Campesan S; Giorgini F; Outeiro TF
Mov Disord; 2021 Aug; 36(8):1744-1758. PubMed ID: 33939203
[TBL] [Abstract][Full Text] [Related]
17. LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease?
O'Hara DM; Pawar G; Kalia SK; Kalia LV
Front Neurosci; 2020; 14():577. PubMed ID: 32625052
[TBL] [Abstract][Full Text] [Related]
18. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
19. Protein misfolding and aggregation in Parkinson's disease.
Tan JM; Wong ES; Lim KL
Antioxid Redox Signal; 2009 Sep; 11(9):2119-34. PubMed ID: 19243238
[TBL] [Abstract][Full Text] [Related]
20. Vesicular Dysfunction and the Pathogenesis of Parkinson's Disease: Clues From Genetic Studies.
Ebanks K; Lewis PA; Bandopadhyay R
Front Neurosci; 2019; 13():1381. PubMed ID: 31969802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
